Register Now: From Clinical to Commercial: Accelerating ADC Late-Stage Development with Technology Innovation and Integrated Platform

Mazen Noureddin

Mazen Noureddin

Mazen Noureddin, MD, MHSc, is a professor of medicine at Houston Methodist Hospital and an internationally recognized leader in steatotic liver disease (SLD) and SLD-related cirrhosis. He founded the Houston Research Institute and serves as chief scientific officer and co-chairman of the board of Summit Clinical Research Solutions. He has led or participated in more than 100 clinical trials and has authored more than 350 peer-reviewed publications, including in The New England Journal of Medicine, The Lancet, and Nature Medicine. In 2026, he received the inaugural Impact Award from the American Association for the Study of Liver Diseases.

Articles by Mazen Noureddin

Latest Updated Articles